Treehub pivots to inception investing for healthcare research commercialization
Treehub is targeting scientists and clinicians within academia to build healthcare companies before formal business models are even established.
Investment firm Treehub is adopting an "inception investing" strategy, focusing on identifying potential founders within academic and medical research settings before they have formally launched a company. The firm argues that the most promising healthcare innovations often remain trapped in research environments because scientists lack the traditional business background required for venture capital pitches.
Traditional venture capital models often favor founders with pre-existing commercial experience and polished pitch decks. Treehub, however, posits that deep, firsthand technical experience in solving clinical problems is more valuable than innate storytelling skills. The firm aims to bridge the gap between academic research and market-ready products by mentoring these subject-matter experts in business strategy and market validation.
This approach involves engaging with researchers while their work is still in the lab phase. By identifying individuals with high domain expertise and focusing on the problems they have spent years studying, Treehub intends to develop businesses from the ground up, rather than evaluating established startups that may lack fundamental innovation.